Porter Derrell — SEC Form 4 filings
SEC reporting owner CIK 1706400. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-23 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 32,300 shares, $75,240 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 13,040 shares @ $2.33 ($30,318) in Acumen Pharmaceuticals, Inc., filed 2026-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | Director | 4 | — | 3 legs · 32,300 sh · $75,240 | 9 |
| Passage BIO, Inc. (PASG) | Director | 3 | — | — | 3 |
Form 4 filings — Porter Derrell
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Option exercise (M): 6,460 @ $1.07 · Sale (S): 6,460 @ $2.35 · Sale (S): 12,800 @ $2.33 · Option exercise (M): 13,040 @ $1.07 · Sale (S): 13,040 @ $2.33 · Option exercise (M): 6,460 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-05 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/award (A): 35,500 @ $0 · Grant/award (A): 53,250 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Passage BIO, Inc. (PASG) | Grant/award (A): 10,539 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/award (A): 12,800 @ $0 · Grant/award (A): 19,500 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Passage BIO, Inc. (PASG) | Grant/award (A): 201,857 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Passage BIO, Inc. (PASG) | Grant/award (A): 47,693 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1706400 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →